Sort
85,873 grants matching “alzheimers”
The U.S. Deprescribing Research Network
$809,610Michael A. Steinman · Northern California Institute/Res/Edu · R33 · FY2025 · AG
Comparative Safety of Seizure Prophylaxis within the Medicare Program
$809,604Lidia Maria Veras Rocha De Moura · Massachusetts General Hospital · R01 · FY2025 · AG
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
$809,599Grigori N Enikolopov · State University New York Stony Brook · R01 · FY2022 · AG
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease
$809,593Karen Macleod · Amprion, Inc. · U44 · FY2022 · NS
Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease
$809,593Karen Macleod · Amprion, Inc. · U44 · FY2021 · NS
Effectiveness of therapeutics and health care services in reducing racial disparities in Alzheimer's disease
$809,565Julie M Zissimopoulos · University Of Southern California · R01 · FY2018 · AG
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes
$809,536Matcheri S. Keshavan · Wayne State University · R01 · FY2007 · MH
MOTS-C, APOE, and Alzheimer's disease
$809,523Christian J Pike · University Of Southern California · R01 · FY2025 · AG
ULTRAFAST OPTICAL PROCESSES LABORATORY
$809,492Robin Main Hochstrasser · University Of Pennsylvania · P41 · FY2007 · RR
Geroscience metabolites beta-hydroxybutyrate and NAD+ linking inflammation and neuroenergetic failure in delirium
$809,451John C Newman · Buck Institute For Research On Aging · R01 · FY2020 · AG
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINE
$809,440Jeanne Mandelblatt · Georgetown University · R01 · FY2011 · CA
Late Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric Symptoms
$809,373Michael Alosco · Boston University Medical Campus · R01 · FY2025 · NS
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimer's disease
$809,297Oleg Butovsky · Brigham And Women'S Hospital · R01 · FY2020 · AG
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in AlzheimerâÂÂs disease
$809,297Oleg Butovsky · Brigham And Women'S Hospital · R01 · FY2021 · AG
Membrane Protein Effectors of Pathogen Interactions With Host
$809,250Francesca M Marassi · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2021 · GM
Preventing Tau uptake by novel inhibitors of tau binding to LRP1
$809,235Kenneth S Kosik · University Of California Santa Barbara · R01 · FY2024 · AG
Neuropathology Core
$809,209Richard Justin Perrin · Northern California Institute/Res/Edu · U19 · FY2023 · AG
Translational big data analytic approaches to advance drug repurposing for Alzheimer's disease
$809,200Li Shen · University Of Pennsylvania · R01 · FY2021 · AG
Functional Connectivity Network in default mode regions provides the underlying infrastructure for task-based functional co-de/activation networks
$809,149Qolamreza Ray Razlighi · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AG
Next-Gen ethnography to understand decision-making among diverse populations impacted by Alzheimer's disease and related dementias (ADRD)
$809,144Daniel P Dohan · University Of California, San Francisco · DP1 · FY2025 · AG
Neuroimaging of Brain Circuits and Neurogenetic Mechanisms in Normal Cognition
$809,007Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2012 · MH
ALZHEIMER'S ASSOCIATION TO PARTNER AND IMPLEMENT PUBLIC HEALTH STRATEGIES
$809,000Walker Tisdale · Alzheimer'S Association · U58 · FY2006 · DP
CHCHD10 Frontotemporal Dementia, Molecular Mechanisms and Therapeutic Strategies
$808,996Hibiki Fujita · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS
Ligand discovery for delineating cholesterol homeostasis in the brain
$808,990Steven H Liang · Massachusetts General Hospital · R01 · FY2021 · AG
Influence of the Menopausal Transition and Lifetime Ovarian Exposure on Neural Metabolism, Connectivity and Pathology
$808,819Joseph M Andreano · Massachusetts General Hospital · R01 · FY2025 · AG